CUPERTINO, Calif.–BioImagene, the leading provider of innovative digital pathology solutions, today announced the appointment of Doug Sweet as Vice President of Sales and Marketing. Mr. Sweet has more than 30 years of experience in business development, marketing and sales in the Diagnostic Industry – Clinical and Anatomic Pathology, Life Science and BioPharma. Dr. Ajit Singh, […]
STAMFORD, Conn.–FUJIFILM Corporation announced that Wyeth (NYSE: WYE) has purchased an AP-3000 label-free surface plasmon resonance (SPR) detection system. The AP-3000 will support Wyeth’s medicinal chemistry department in screening small chemical fragments during drug discovery. Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. Using a proprietary, high-sensitivity SPR biosensor, […]
KNOXVILLE, TN–(February 26, 2009) – Protein Discovery, Inc., a privately held life sciences company, today announced that it has hired Jeffrey A. Komatz for the position of chief financial officer. Mr. Komatz will be responsible for ensuring the continued financial health of Protein Discovery. As the CFO, Mr. Komatz will plan and manage the company’s […]
HERCULES, CA – February 26, 2009 – Bio-Rad Laboratories, Inc, (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the company, Novartis Institutes for BioMedical Research and Nonlinear Dynamics are coordinating the proteomics community’s efforts to develop standards and validated protocols that will ensure reproducibility […]
MADISON, Wis.–Promega Corporation announces the availability of the new pmirGLO Dual-Luciferase miRNA Target Expression Vector. pmirGLO supports both breadth and depth in the microRNA study. Researchers have both ability to measure a wide dynamic range of miRNA activity in a vast number of cell types and the option to create a stable cell line from […]
FREMONT, Calif., Feb. 25 — WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced positive data on the company’s SmartChip(TM) Real-Time PCR System. These validation results were presented today by WaferGen scientists and collaborative researchers from the University of Pittsburgh […]
Battelle Ventures, LP, has spun out Hepregen Corporation from the Massachusetts Institute of Technology (MIT), with a commitment of a $5-million Series A investment from the fund and its Tennessee affiliate, Innovation Valley Partners. The company, which is developing bioengineered solutions for drug development, received the first $3 million from the funds last summer, leaving […]
SOUTH EASTON, Mass., Feb. 18 — Pressure BioSciences, Inc. (Nasdaq: PBIO – News; “PBI” or the “Company”) today announced that it has received $1.8 million from the sale of 156,980 units in a private placement that closed on Thursday, February 12, 2009. Each unit was priced at $11.50 and consists of (i) one share of […]
The Fluidigm 48.48 Dynamic Array from Fluidigm Europe provides a highly efficient solution for single cell gene expression quantification studies using off-the-shelf TaqMan® PCR assays and reagents. Historically, single-cell gene expression experiments have been difficult and expensive to perform. Fluidigm has introduced a new single-cell gene expression technique that, when used with the BioMark™ System, […]
Study Results Published in Blood, Journal of the American Society of Hematology SAN DIEGO–Sequenom, Inc. (NASDAQ:SQNM – News), a leading provider of genetic analysis solutions, today announced results of a large, multicenter retrospective study from the Children’s Hospital Oakland Research Institute and the University of Minnesota Cancer Center showing that donors with more stimulatory natural […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
